Stockreport

Gilead increases number of participants in two trials for experimental COVID-19 treatment [MarketWatch]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF Gilead Sciences Inc. increased the number of participants in two ongoing clinical trials for remdesivir, its experimental treatment for COVID-19. According to ClinicalTr [Read more]